Metrics to compare | 099190 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship099190PeersSector | |
|---|---|---|---|---|
P/E Ratio | −86.8x | 7.9x | −0.4x | |
PEG Ratio | 0.14 | 0.01 | 0.00 | |
Price/Book | 1.5x | 0.8x | 2.6x | |
Price / LTM Sales | 1.6x | 1.0x | 3.1x | |
Upside (Analyst Target) | 105.7% | 65.0% | 48.9% | |
Fair Value Upside | Unlock | 40.5% | 6.2% | Unlock |
i-SENS, Inc. engages in the development, manufacture, and sale of sensors and measuring instruments based on electrochemical and biosensor technologies in South Korea and internationally. The company offers blood glucose monitoring devices; measuring instruments and point-of-care diagnostic devices (POCT), biosensor technologies, diabetes care, acute care, and coagulation care devices; veterinary care devices; and IVD systems. It also provides SmartLog, diabetes management software for mobile and PC. The company was founded in 2000 and is headquartered in Seoul, South Korea.